SCHEMBL8556230

SCHEMBL8556230

O=C1c2ccccc2C(=O)N1CCN1CCOCC1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 1/20 0.66
SMN1; SMN2 Q16637 2/20 0.63
HTR1A P08908 4/20 0.62
DRD2 P14416 1/20 0.62
HTR6 P50406 1/20 0.62
MEN1 O00255 2/20 0.61
KMT2A Q03164 2/20 0.61
NPSR1 Q6W5P4 1/20 0.61
LMNA P02545 1/20 0.60
ALDH1A1 P00352 2/20 0.57
NPC1 O15118 1/20 0.57
CYP1A2 P05177 1/20 0.57
CYP2C19 P33261 1/20 0.57
RAB9A P51151 1/20 0.57
KDM4E B2RXH2 1/20 0.57
MAPT P10636 1/20 0.57
CA1 P00915 1/20 0.56
CA2 P00918 1/20 0.56
ALDH3A1 P30838 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27657032 0.98 GRM5 (0.64) GRM5SMN1; SMN2HTR1ADRD2HTR6
SCHEMBL1463660 0.92 HTR1A (0.69) HTR1ADRD2HTR6MEN1KMT2A
SCHEMBL8556091 0.92 HTR1A (0.73) SMN1; SMN2HTR1ADRD2HTR6MEN1
SCHEMBL8554700 0.90 HTR1A (0.69) HTR1ADRD2HTR6MEN1KMT2A
SCHEMBL8559095 0.90 HTR1A (0.69) HTR1ADRD2HTR6MEN1KMT2A
SCHEMBL8559706 0.90 HTR1A (0.69) HTR1ADRD2HTR6MEN1KMT2A
SCHEMBL1703636 0.90 HTR1A (0.69) HTR1ADRD2HTR6MEN1KMT2A
SCHEMBL8559799 0.90 HTR1A (0.69) HTR1ADRD2HTR6MEN1KMT2A
SCHEMBL23164620 0.89 HTR1A (0.67) HTR1A
SCHEMBL12332512 0.89 HTR1A (0.67) HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0575954-B1 Aminoalkylcarbamic esters of eseroline suitable for use as cholinesterase acitivity inhibitors and relative preparation process MEDIOLANUM FARMACEUTICI SRL (IT) 1998-09-02 EP disclosed
US-5424451-A Used as cholinesterase activity inhibitors MEDIOLANUM FARMACEUTICI S.P.A. (IT) 1995-06-13 US disclosed
US-5302593-A Aminoalkylcarbamic esters of eseroline suitable for use as chlorinesterase activity inhibitors MEDIOLANUM FARMACEUTICI S.P.A. (IT) 1994-04-12 US disclosed
EP-0575954-A1 Aminoalkylcarbamic esters of eseroline suitable for use as cholinesterase acitivity inhibitors and relative preparation process MEDIOLANUM FARMACEUTICI S.P.A. (IT) 1993-12-29 EP disclosed